CA
AKRO

Clearstead Advisors’s Akero Therapeutics AKRO Stock Holding History

Clearstead Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26
Closed -$1.24K – 2752
2025
Q3 		$1.24K Buy
+26
New +$1.26K ﹤0.01% 2578

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clearstead Advisors's AKRO Position: Q4 2025 in Review

Clearstead Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 26 shares — an estimated $1.24K sold.

Clearstead Advisors first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $1.24K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Clearstead Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Clearstead Advisors sold 26 Akero Therapeutics shares in Q4 2025, an estimated $1.24K.
  • Clearstead Advisors first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Clearstead Advisors's Akero Therapeutics position peaked at $1.24K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.